Calliditas Therapeutics — Major Shareholding Notification 2018

Aug 1, 2018

Issuer Calliditas Therapeutics AB

Holder

Stiftelsen Industrifonden

Instrument

Instrument	Ordinary shares SE0010441584
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Share loan
Date	01/08/2018
Limit for number of shares	20 %
Limit for number of votes	20 %
After the transaction
Quantity
Shares	7,732,538
Directly held voting rights	7,732,538
Indirectly held voting rights	0
Percentage
Directly held shares	21.96597 %
Directly held voting rights	21.96597 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	21.96597 %	7,732,538
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled
- Cash settled
Total	21.96597 %	7,732,538
Group total holdings

Voting rights 7,732,538 Percentage of voting rights 21.96597

Notes (other relevant informations according to law)

Flaggningen avser återleverans av utlånade aktier i samband med noteringen av Calliditas aktie på Nasdaq Stockholm samt emission av nya aktier i Calliditas den 29 juli.

Published

01/08/2018 14:26

Contact

Name Jonas Jendi Phone +46738000848 Email jonas.jendi@industrifonden.com

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25